Home
Conditions
Respiratory Hypersensitivity

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,459 public trials 325 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

Oral Probiotic Administration to Modulate the Airway Microbiome in Obese Asthmatic Subjects

NCT03157518

Conditions: Asthma, Body Weight, Bronchial Diseases, +14 more
Locations: UAB Lung Health Center Birmingham, Alabama, United States

View Trial Details

Completed

Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)

NCT03444506

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Glenmark Investigational Site 1 Mississauga, Ontario, Canada

View Trial Details

Completed

Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma

NCT01687296

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +10 more
Locations: GSK Investigational Site Changsha, Hunan, China

GSK Investigational Site Yanji, Jilin, China

GSK Investigational Site Shenyang, Liaoning, China

GSK Investigational Site Wenzhou, Zhejiang, China

View Trial Details

Completed

A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol

NCT01540708

Conditions: Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations: GSK Investigational Site Randwick, New South Wales, Australia

View Trial Details

Completed

A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer

NCT02045953

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

ROTAHALER Device Optimization Study

NCT01890863

Conditions: Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations: GSK Investigational Site Randwick, New South Wales, Australia

View Trial Details

Completed

Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.

NCT01984086

Conditions: Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations: GSK Investigational Site Randwick, New South Wales, Australia

View Trial Details

Completed

Factors That Affect the Development of COPD Symptoms

NCT00740337

Conditions: Chronic Disease, Disease Attributes, Emphysema, +14 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy

NCT02075255

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Research Site Los Angeles, California, United States

Research Site Centennial, Colorado, United States

Research Site Denver, Colorado, United States

Research Site Hialeah, Florida, United States

View all 87 locations

View Trial Details

Completed

Community Empowerment to Pilot a Novel Device for Monitoring Rescue Medication Use in Urban Children With Asthma

NCT02517047

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Respiratory Hypersensitivity

Respiratory Hypersensitivity trial results

Related conditions